With a presence in 28 countries, this acquisition further strengthens its position as the leading pan-African distributor of pharmaceutical products ...

The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

The Digital Markets, Competition and Consumers Act 2024 (UK DMCC) introduces significant reforms to the UK’s Competition and Markets Authority ...

The announcements by Cigna, CVS, Humana, Centene, and UnitedHealth were made ahead of the beginning of Medicare Advantage enrollment, which begins Oct. 15. Among other news, a top California health ...

Sanofi has asked bidders to revise their proposals for its consumer health unit, people with knowledge of the matter said, as ...

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer ...

The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...

The success of a leveraged buyout (LBO) strategy depends, in large part, on the availability of leverage. When debt is scarce ...

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...